Clinical Trial of STHLM3 and MRI
Tobias Nordstrom, MD, PhD, discusses the STHLM3 blood test and prostate cancer diagnostics, studied in a recent clinical trial.
Read MoreSelect Page
Clinical urologist and researcher dedicated to improve diagnostics and treatment of prostate cancer and other urological conditions. Tobias Nordström is a clinically active urologist, focusing on the detection and treatment of malignancies in the prostate and kidney, as well as treating general urological conditions. He started practicing urology in 2007 and has achieved degrees in General Surgery and Urology at Danderyd's Hospital. He was awarded Fellow of the European Board of Urology (FEBU) in 2015.
Tobias Nordström defended his thesis "Predicting Prostate Cancer- on the use of biomarkers in Prostate Cancer Diagnostics" in January 2015 after which he undertook international postdoctoral studies at University of California, San Francisco. He now combines clinical surgical practice at Danderyds Hospital with independent research at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. Centrepieces of his work includes leading guidelines development and implementing improvements in clinical care such as targeted prostate biopsies and imaging.
Posted by Tobias Nordstrom, MD, PhD | Jun 2024
Tobias Nordstrom, MD, PhD, discusses the STHLM3 blood test and prostate cancer diagnostics, studied in a recent clinical trial.
Read More